Eli Lilly and Company CEDEAR (LLY)
BCBA
Closed
Aug 24, 2026
Day's Range
35,220.0052 wk Range
16,825.00Overview - LLY - Eli Lilly and Company CEDEAR
Key Statistics
Valuation
Enterprise Value
1,444,941.87T
P/E (Trailing)
‪0.20‬
PEG Ratio
‪0.0076‬
Price / Sales (TTM)
‪99.97‬
Price / Book
‪19.03‬
EV / EBITDA
‪23,147.49‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
26.93B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪33,044.40‬
200-Day Avg
‪28,619.50‬
Dividends
Payout Ratio
‪0.10%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LLY - Eli Lilly and Company CEDEAR
Peers - LLY - Eli Lilly and Company CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- LLYBCBAEli Lilly and Company CEDEAR7.96TMarket Cap+52.71%52-week change0.20P/E (Trailing)‪33.52%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,355.89TMarket Cap+43.62%52-week change60.24P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR345.82TMarket Cap+43.38%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR167.51TMarket Cap+35.56%52-week change17.39P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR102.70TMarket Cap+17.93%52-week change6.54P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt74.67TMarket Cap+33.27%52-week change7.97P/E (Trailing)‪9.80%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.72.76TMarket Cap+40.06%52-week change5.24P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - LLY - Eli Lilly and Company CEDEAR
About
Eli Lilly and Company CEDEAR is a depositary certificate representing shares of a leading global biopharmaceutical firm through the Argentine market infrastructure. Its primary purpose is to provide local investors access, in local custody and settlement, to the economic rights of Eli Lilly and Company, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
